The Johns Hopkins Sidney Kimmel Cancer Center — Baltimore, Maryland

The Johns Hopkins Sidney Kimmel Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21287.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

The Johns Hopkins Sidney Kimmel Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype.

Sponsors: T-MAXIMUM Pharmaceutical Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Johns Hopkins Sidney Kimmel Cancer Center?

The Johns Hopkins Sidney Kimmel Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Johns Hopkins Sidney Kimmel Cancer Center conducted?

The Johns Hopkins Sidney Kimmel Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype.

Is The Johns Hopkins Sidney Kimmel Cancer Center accredited by Crixeo Health?

The Johns Hopkins Sidney Kimmel Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Johns Hopkins Sidney Kimmel Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.